Antitumor activity of the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 (‘lressa’), alone or combined with gemcitabine and vinorelbine platinum-based chemotherapy, in human non-small-cell lung cancer (NSCLC) xenografts

• Book ID: 117659540
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 132 KB
• Volume: 38
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(02)80848-6